Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix

AB Costales, AM Milbourne, HE Rhodes, MF Munsell, John Joseph Wallbillich, J Brown, Michael M. Frumovitz, LM Ramondetta, KM Schmeler

Research output: Contribution to journalArticle

17 Citations (Scopus)
Original languageEnglish (US)
Article number23541795
Pages (from-to)513-516
Number of pages4
JournalGynecologic Oncology
Volume129
Issue number3
DOIs
StatePublished - Jun 2013

Cite this

Costales, AB., Milbourne, AM., Rhodes, HE., Munsell, MF., Wallbillich, J. J., Brown, J., ... Schmeler, KM. (2013). Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix. Gynecologic Oncology, 129(3), 513-516. [23541795]. https://doi.org/10.1016/j.ygyno.2013.03.015

Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix. / Costales, AB; Milbourne, AM; Rhodes, HE; Munsell, MF; Wallbillich, John Joseph; Brown, J; Frumovitz, Michael M.; Ramondetta, LM; Schmeler, KM.

In: Gynecologic Oncology, Vol. 129, No. 3, 23541795, 06.2013, p. 513-516.

Research output: Contribution to journalArticle

Costales, AB, Milbourne, AM, Rhodes, HE, Munsell, MF, Wallbillich, JJ, Brown, J, Frumovitz, MM, Ramondetta, LM & Schmeler, KM 2013, 'Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix', Gynecologic Oncology, vol. 129, no. 3, 23541795, pp. 513-516. https://doi.org/10.1016/j.ygyno.2013.03.015
Costales AB, Milbourne AM, Rhodes HE, Munsell MF, Wallbillich JJ, Brown J et al. Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix. Gynecologic Oncology. 2013 Jun;129(3):513-516. 23541795. https://doi.org/10.1016/j.ygyno.2013.03.015
Costales, AB ; Milbourne, AM ; Rhodes, HE ; Munsell, MF ; Wallbillich, John Joseph ; Brown, J ; Frumovitz, Michael M. ; Ramondetta, LM ; Schmeler, KM. / Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix. In: Gynecologic Oncology. 2013 ; Vol. 129, No. 3. pp. 513-516.
@article{ba83d7e5deef4f7b9e7b8ef653d424b2,
title = "Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix",
author = "AB Costales and AM Milbourne and HE Rhodes and MF Munsell and Wallbillich, {John Joseph} and J Brown and Frumovitz, {Michael M.} and LM Ramondetta and KM Schmeler",
year = "2013",
month = "6",
doi = "10.1016/j.ygyno.2013.03.015",
language = "English (US)",
volume = "129",
pages = "513--516",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix

AU - Costales, AB

AU - Milbourne, AM

AU - Rhodes, HE

AU - Munsell, MF

AU - Wallbillich, John Joseph

AU - Brown, J

AU - Frumovitz, Michael M.

AU - Ramondetta, LM

AU - Schmeler, KM

PY - 2013/6

Y1 - 2013/6

U2 - 10.1016/j.ygyno.2013.03.015

DO - 10.1016/j.ygyno.2013.03.015

M3 - Article

VL - 129

SP - 513

EP - 516

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

M1 - 23541795

ER -